BIODESIX INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Biodesix Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2020 to Q1 2024.
  • Biodesix Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $791K.
  • Biodesix Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $29.1M, a 50.5% decline from 2022.
  • Biodesix Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $58.9M, a 4566% increase from 2021.
  • Biodesix Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $1.26M, a 98.4% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $791K +$3.21M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 -$2.42M +$413K +14.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 -$2.83M -$7.79M -157% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $4.95M -$1.47M -22.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $6.42M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.